16-2093545-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM5BP4_StrongBP6BS2
The NM_001009944.3(PKD1):c.11015G>A(p.Arg3672Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000637 in 1,597,364 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3672W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001009944.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.11015G>A | p.Arg3672Gln | missense_variant, splice_region_variant | 37/46 | ENST00000262304.9 | |
PKD1-AS1 | NR_135175.1 | n.303+533C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.11015G>A | p.Arg3672Gln | missense_variant, splice_region_variant | 37/46 | 1 | NM_001009944.3 | P5 | |
PKD1-AS1 | ENST00000563284.3 | n.194+533C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152172Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000402 AC: 90AN: 223828Hom.: 1 AF XY: 0.000462 AC XY: 56AN XY: 121142
GnomAD4 exome AF: 0.000664 AC: 960AN: 1445072Hom.: 1 Cov.: 32 AF XY: 0.000658 AC XY: 472AN XY: 717298
GnomAD4 genome AF: 0.000381 AC: 58AN: 152292Hom.: 1 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | PKD1: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jul 23, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2021 | The c.11012G>A (p.R3671Q) alteration is located in exon 37 (coding exon 37) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 11012, causing the arginine (R) at amino acid position 3671 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 01, 2019 | - - |
Polycystic kidney disease Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Arg3672Gln variant was not identified in the literature nor was it identified in the PKD1-LOVD. The variant was identified in dbSNP (ID: rs201220835) as "With other allele", ClinVar (classified as likely benign by ARUP; as uncertain significance by Athena Diagnostics), LOVD 3.0, and ADPKD Mutation Database (as likely neutral). The variant was also identified in our laboratory with a co-occurring pathogenic PKD1 variant (PKD1 c.5510G>A (p.Trp1837X)), increasing the likelihood that the p.Arg3672Gln variant does not have clinical significance. The variant was identified in control databases in 108 of 249596 chromosomes (2 homozygous) at a frequency of 0.0004 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 4 of 21718 chromosomes (freq: 0.0002), Other in 2 of 5944 chromosomes (freq: 0.0003), Latino in 6 of 32178 chromosomes (freq: 0.0002), European in 83 of 112264 chromosomes (freq: 0.000739), EastAsian in 1 of 17524 chromosomes (freq: 0.000057), and South Asian in 12 of 27884 chromosomes (freq: 0.0004), while the variant was not observed in the Ashkenazi Jewish, and Finnish, populations. The p.Arg3672 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The c.11015G>A variant occurs in the last three bases of the exon. This position has been shown to be part of the splicing consensus sequence and variants involving this position sometimes affect splicing. In addition, 2 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
PKD1-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 16, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at